CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
23,306,553
Share change
-4,621,979
Total reported value
$18,884,089
Price per share
$0.81
Number of holders
36
Value change
-$3,721,274
Number of buys
10
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q1 2022

As of 31 Mar 2022, CASI PHARMACEUTICALS INC - COM (CASI) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,306,553 shares. The largest 10 holders included FEDERATED HERMES, INC., VANGUARD GROUP INC, Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, Ikarian Capital, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, FRANKLIN RESOURCES INC, and STATE STREET CORP. This page lists 36 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.